2021.04.16 FDA 【対訳版】Remote Interactive Evaluations of Drug Manufacturing Establishments(COVID-19 公衆衛生緊急事態中の医薬品製造及び バイオリサーチモニタリング施設の リモートインタラクティブ評価 業界向けガイダンス)
FDA 510(k) 2019.02.18 Refuse to Accept Policy for 510(k)s COPY TITLE&URL Refuse to Accept Policy for 510(k)s ]]> Tweet Share Hatena Pocket RSS feedly Pin it Guidance for the Content of Premarket Submissions for Software Contained... Previous post The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)] Next post
FDA 510(k) 2019.02.18 The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)]
Comment